Stay updated with breaking news from Research learning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Watch American History tv this weekend on cspan 3. You are watching American History tv. Every weekend on cspan 3, explore our nations past. Created by americas Cable Television companies as a public service, and brought to you today by your television provider. Next on American History tv, to bestselling authors discuss how they use Historical Research in their work. Novelist Kathleen Rouhanis latest as the world war one story, and miles harvey focuses on his new nonfiction book, the king of confidence. The conversation was moderated by the Paul University professor amy tyson. Authors ....
Depaul English Department and cohosted by Depaul History Department. Its a thrill to get to host an event with two real stalwarts of the English Department, Kathleen Rooney and miles harvey. Amazing writers and researchers. Were very grateful to have amy tyson from the Depaul History Department to present and interview them. I also want to thank all of you especially for being here. Its always so meaningful to feel support for artists and the arts. During this difficult time when bombast and quick takes seem to rule the day, a lot of us recognize its the quieter, more thoughtful creations that actually sustain us. So, that said, i would encourage you, if you like what you hear ton ....
Who was assassinated on friday to promise retaliation in what its calling to tom. And in sports, a frightening crash leaves racing fans. But formula one driver remained gross. You escaped with his life and walked away from this a great bowl of coffee. Its good to have you with us tonight with the corona virus continuing to impact life around the world. The race for and approved vaccine is on. Now u. S. Drug firm mcdermott says its applying for emergency approval of its coated 1000 vaccine in both europe and the u. S. Now that could lead to distribution in the u. S. As soon as december, the company says full trial results show its vaccine was 94 percent effective. With no serious safety concerns, the filing sets up mcgurn as a product to be the 2nd vaccine likely to receive special authorization after one developed by pfizer and bio on 10 are joining me now is young. Its not says he is with the European Public health alliance. He ....